查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594391

基於 NGS 的 RNA定序市場：按產品和服務、技術、應用和最終用戶分類 - 2025-2030 年全球預測

NGS-Based RNA-Sequencing Market by Product & Services, Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年基於NGS的RNA定序市值為23.2億美元，預計2024年將達到26.7億美元，複合年成長率為17.32%，到2030年將達到71.2億美元，預計將達到1000萬美元。

基於 NGS 的 RNA定序能夠對轉錄組進行全面分析，透過提供對基因表現的詳細見解、發現新的轉錄本以及增進對基因調控機制的理解，正在徹底改變基因組學研究。對 RNA定序的需求源於其提供準確、高通量資料的能力，這對於推動個人化醫療、識別新的治療標靶和理解複雜的生物系統至關重要。應用範圍從腫瘤學到神經學，在疾病研究、診斷和藥物發現中發揮重要作用。最終用途市場多種多樣，包括學術和研究機構、臨床診斷實驗室、製藥公司和生物技術公司，展示了廣泛的應用。市場成長受到以下因素的支持：對個人化醫療的日益偏好、基因組研究資金的增加以及測序技術的進步降低了成本並提高了可及性。新興的商機包括整合人工智慧和機器學習進行資料分析，加強RNA定序在非模型生物和未充分研究的疾病中的應用，以及擴大效用。公司應專注於與研究機構合作，推動創新並探索獨特的定序應用。然而，初始成本高、資料複雜性以及對先進基礎設施的需求等限制因素為市場擴張帶來了挑戰。有關遺傳資料的監管複雜性和倫理問題使情況更加複雜。創新機會包括推進定序技術以提供更快、更具成本效益的解決方案、開發強大的資料分析工具以簡化解釋以及方便用戶使用性以實現民主化。隨著市場的成熟，利用雲端運算進行資料儲存和運算將變得至關重要，而策略性產學合作將成為探索新機會的核心。 RNA定序市場充滿活力且快速發展，隨著它與醫學創新和研究的前沿更加契合，其強勁的成長潛力顯而易見。

主要市場統計
基準年[2023] 23.2億美元
預測年份 [2024] 26.7億美元
預測年份 [2030] 71.2億美元
複合年成長率（%） 17.32%

市場動態：揭示快速發展的基於 NGS 的 RNA定序市場的關鍵市場洞察

基於 NGS 的 RNA定序市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 次世代定序儀的快速採用
    • 精準醫學的強勁成長和 RNA 定序津貼的增加
    • 對先進的基於序列的診斷的需求不斷成長
  • 市場限制因素
    • NGS設備成本高
  • 市場機會
    • RNA定序技術進步
    • 與 RNA定序相關的研究活動增加
  • 市場問題
    • 缺乏熟練人才

波特五力：駕馭基於 NGS 的 RNA定序市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基於 NGS 的 RNA定序市場的外部影響

外部宏觀環境因素在塑造基於 NGS 的 RNA定序市場的績效動態發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解基於NGS的RNA定序市場的競爭格局

基於 NGS 的 RNA定序市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：基於 NGS 的 RNA定序市場供應商績效評估

FPNV定位矩陣是評估基於NGS的RNA定序市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製基於 NGS 的 RNA定序市場的成功之路

對於想要加強在全球市場的影響力的公司來說，基於 NGS 的 RNA定序市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 次世代定序的快速採用
      • 精準醫療強勁成長，RNA定序津貼增加
      • 對先進的基於序列的診斷的需求不斷成長
    • 抑制因素
      • NGS設備成本高
    • 機會
      • RNA定序技術進步
      • 與 RNA定序相關的研究活動增加
    • 任務
      • 缺乏熟練人才
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章基於NGS的RNA定序市場：依產品和服務分類

  • 介紹
  • 資料分析
  • RNA定序平台與用品
  • RNA定序服務
  • 樣品製備產品
  • 儲存與管理

第7章基於NGS的RNA定序市場：依技術分類

  • 介紹
  • 離子半導體定序
  • 奈米孔定序
  • 合成定定序
  • 單分子即時定序

第8章基於NGS的RNA定序市場：依應用分類

  • 介紹
  • 從頭轉錄組組裝
  • 表達譜分析
  • 小規模RNA定序
  • 變異調用和轉錄組表觀遺傳學

第 9 章 基於 NGS 的 RNA定序市場：依最終使用者分類

  • 介紹
  • 醫院/診所
  • 製藥和生物技術公司
  • 研究和學術

第10章 美洲基於NGS的RNA定序市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區基於NGS的RNA定序市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲基於NGS的RNA定序市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies
  • Becton, Dickinson and Company
  • BGI Group
  • Eurofins Scientific
  • F. Hoffmann-la Roche AG
  • Genewiz by Brooks Automation, Inc.
  • Hamilton Company
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Nanopore Technologies
  • PerkinElmer, Inc.
  • Psomagen
  • Qiagen NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific
Product Code: MRR-2214614769D5

The NGS-Based RNA-Sequencing Market was valued at USD 2.32 billion in 2023, expected to reach USD 2.67 billion in 2024, and is projected to grow at a CAGR of 17.32%, to USD 7.12 billion by 2030.

NGS-Based RNA-Sequencing, which enables comprehensive analysis of the transcriptome, promises to revolutionize genomics research by providing detailed insights into gene expression, discovery of novel transcripts, and enhanced understanding of gene regulation mechanisms. The necessity of RNA-Sequencing arises from its ability to deliver precise, accurate, and high-throughput data essential for advancing personalized medicine, identifying new therapeutic targets, and understanding complex biological systems. Applications span from oncology to neurology, playing a crucial role in disease research, diagnostics, and drug discovery. End-use markets encompass academic and research institutes, clinical diagnostics labs, pharmaceutical and biotech companies, underscoring broad application versatility. Market growth is underpinned by factors such as increasing preference for personalized medicine, growing funding for genomic research, and technological advancements in sequencing technology that drive down costs and improve accessibility. Latest opportunities include integrating AI and machine learning for data analysis, enhancing the application of RNA-Sequencing in non-model organisms and less-studied diseases, and expanding its utility in biomarker discovery and precision medicine. Companies should focus on collaborations with research institutions to drive innovation and explore unique sequencing applications. However, limitations like high initial costs, data complexity, and the requisite for sophisticated infrastructure challenge market expansion. Regulatory complexities and ethical concerns related to genetic data further complicate the landscape. Innovation opportunities lie in advancing sequencing technologies to offer faster and more cost-efficient solutions, developing robust data analysis tools to streamline interpretations, and focusing on user-friendly platforms to democratize access. As the market matures, leveraging cloud computing for data storage and computation will be vital, and strategic industry-academic collaborations will be central to exploring nascent opportunities. The RNA-Sequencing market is dynamic and rapidly evolving, marked by robust growth potential as it aligns increasingly with healthcare innovation and research frontiers.

KEY MARKET STATISTICS
Base Year [2023] USD 2.32 billion
Estimated Year [2024] USD 2.67 billion
Forecast Year [2030] USD 7.12 billion
CAGR (%) 17.32%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving NGS-Based RNA-Sequencing Market

The NGS-Based RNA-Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in the adoption of next-generation sequencing
    • Robust growth of precision medicines and rising amount of RNA sequencing grants
    • Increasing demand for advanced sequencing-based diagnostics
  • Market Restraints
    • Cost of NGS instruments is high
  • Market Opportunities
    • Technological advancement in the RNA-Sequencing
    • Increasing research activities related to RNA-Sequencing
  • Market Challenges
    • Unavailability of skilled manpower

Porter's Five Forces: A Strategic Tool for Navigating the NGS-Based RNA-Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the NGS-Based RNA-Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the NGS-Based RNA-Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the NGS-Based RNA-Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the NGS-Based RNA-Sequencing Market

A detailed market share analysis in the NGS-Based RNA-Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the NGS-Based RNA-Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the NGS-Based RNA-Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the NGS-Based RNA-Sequencing Market

A strategic analysis of the NGS-Based RNA-Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the NGS-Based RNA-Sequencing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Becton, Dickinson and Company, BGI Group, Eurofins Scientific, F. Hoffmann-la Roche AG, Genewiz by Brooks Automation, Inc., Hamilton Company, Illumina, Inc., Merck KGaA, Oxford Nanopore Technologies, PerkinElmer, Inc., Psomagen, Qiagen N.V., Takara Bio Inc., and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the NGS-Based RNA-Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Services, market is studied across Data Analysis, RNA Sequencing Platforms & Consumables, RNA Sequencing Services, Sample Preparation Products, and Storage & Management.
  • Based on Technology, market is studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing By Synthesis, and Single-Molecule Real-Time Sequencing.
  • Based on Application, market is studied across De Novo Transcriptome Assembly, Expression Profiling Analysis, Small RNA Sequencing, and Variant Calling & Transcriptome Epigenetics.
  • Based on End-User, market is studied across Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research & Academia.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in the adoption of next-generation sequencing
      • 5.1.1.2. Robust growth of precision medicines and rising amount of RNA sequencing grants
      • 5.1.1.3. Increasing demand for advanced sequencing-based diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Cost of NGS instruments is high
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the RNA-Sequencing
      • 5.1.3.2. Increasing research activities related to RNA-Sequencing
    • 5.1.4. Challenges
      • 5.1.4.1. Unavailability of skilled manpower
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. NGS-Based RNA-Sequencing Market, by Product & Services

  • 6.1. Introduction
  • 6.2. Data Analysis
  • 6.3. RNA Sequencing Platforms & Consumables
  • 6.4. RNA Sequencing Services
  • 6.5. Sample Preparation Products
  • 6.6. Storage & Management

7. NGS-Based RNA-Sequencing Market, by Technology

  • 7.1. Introduction
  • 7.2. Ion Semiconductor Sequencing
  • 7.3. Nanopore Sequencing
  • 7.4. Sequencing By Synthesis
  • 7.5. Single-Molecule Real-Time Sequencing

8. NGS-Based RNA-Sequencing Market, by Application

  • 8.1. Introduction
  • 8.2. De Novo Transcriptome Assembly
  • 8.3. Expression Profiling Analysis
  • 8.4. Small RNA Sequencing
  • 8.5. Variant Calling & Transcriptome Epigenetics

9. NGS-Based RNA-Sequencing Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Pharmaceutical & Biotechnology Companies
  • 9.4. Research & Academia

10. Americas NGS-Based RNA-Sequencing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific NGS-Based RNA-Sequencing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa NGS-Based RNA-Sequencing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies
  • 2. Becton, Dickinson and Company
  • 3. BGI Group
  • 4. Eurofins Scientific
  • 5. F. Hoffmann-la Roche AG
  • 6. Genewiz by Brooks Automation, Inc.
  • 7. Hamilton Company
  • 8. Illumina, Inc.
  • 9. Merck KGaA
  • 10. Oxford Nanopore Technologies
  • 11. PerkinElmer, Inc.
  • 12. Psomagen
  • 13. Qiagen N.V.
  • 14. Takara Bio Inc.
  • 15. Thermo Fisher Scientific

LIST OF FIGURES

  • FIGURE 1. NGS-BASED RNA-SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. NGS-BASED RNA-SEQUENCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NGS-BASED RNA-SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NGS-BASED RNA-SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NGS-BASED RNA-SEQUENCING MARKET DYNAMICS
  • TABLE 7. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING PLATFORMS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STORAGE & MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DE NOVO TRANSCRIPTOME ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY EXPRESSION PROFILING ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SMALL RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY VARIANT CALLING & TRANSCRIPTOME EPIGENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. NGS-BASED RNA-SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023